Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Ophthalmology therapeutics Market Research Reports

Titlepublishedprice

Blepharitis (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, and occasionally allergies. Blepharitis signs and symptoms include watery ......"
30-Jul-2021$2000

Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... e Juvenile Macular Degeneration (Ophthalmology) pipeline landscape. Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults. The most common form of juvenile macular degeneration is Sta......"
30-Jul-2021$2000

Ocular Hypertension (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... peline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up,......"
30-Jul-2021$2000

Optic Neuropathy (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... ndscape. Optic neuropathy is an inherited form of vision loss. Symptoms include eye pain or discomfort, numbness, tingling and clouding of vision. Predisposing factors include age, tobacco smoke, alcohol, cancer treating drugs, stress re......"
30-Jul-2021$2000

Proliferative Vitreoretinopathy (PVR) (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... ative Vitreoretinopathy (Ophthalmology) pipeline landscape. Proliferative Vitreoretinopathy (PVR) occurs when a scar forms under or on the retina after retinal detachment, preventing the retina from healing and falling back into place. R......"
30-Jul-2021$2000

Leber Congenital Amaurosis (LCA) (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... maurosis (Genetic Disorders) pipeline landscape. Leber congenital amaurosis is an eye disorder that primarily affects the retina, which is the specialized tissue at the back of the eye that detects light and color. This condition is the ......"
30-Jul-2021$2000

Bacterial Conjunctivitis (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... hthalmology) pipeline landscape. Bacterial conjunctivitis is an inflammation of the conjunctiva caused by pathogenic bacteria. Bacterial conjunctivitis is usually caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus sp,......"
30-Jul-2021$2000

Glaucoma (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... aucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. The most imp......"
30-Jul-2021$2500

Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... ivitis Sicca (Ophthalmology) pipeline landscape. Keratoconjunctivitis sicca (KCS) or dry eye disease (DED) or dry eye syndrome (DES) is a condition in which a person experience desiccation of the conjunctiva and cornea due to an inadequa......"
30-Jul-2021$2000

Uveitis (Ophthalmology) - Drugs In Development, 2021

By Global Markets Direct
"...... is is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Sympt......"
30-Jul-2021$2000

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy